Zhonghui Lu

679 total citations
12 papers, 370 citations indexed

About

Zhonghui Lu is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Zhonghui Lu has authored 12 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Zhonghui Lu's work include Cytokine Signaling Pathways and Interactions (5 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). Zhonghui Lu is often cited by papers focused on Cytokine Signaling Pathways and Interactions (5 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). Zhonghui Lu collaborates with scholars based in United States, Germany and Sweden. Zhonghui Lu's co-authors include James J.‐W. Duan, Rui‐Qin Liu, Maryanne Covington, Carl P. Decicco, Robert Newton, Mingxin Qian, David D. Christ, Zelda R. Wasserman, Krishna Vaddi and James M. Trzăskos and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Bioorganic Chemistry.

In The Last Decade

Zhonghui Lu

12 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhonghui Lu United States 9 186 169 101 58 40 12 370
John Roderick United States 12 128 0.7× 138 0.8× 95 0.9× 57 1.0× 31 0.8× 14 301
John L. Gilmore United States 14 323 1.7× 235 1.4× 71 0.7× 24 0.4× 37 0.9× 21 525
John G. Catalano United States 12 175 0.9× 236 1.4× 81 0.8× 48 0.8× 22 0.6× 17 413
Attilla Ting United Kingdom 13 100 0.5× 267 1.6× 164 1.6× 92 1.6× 58 1.4× 17 467
Manfred Schudok Germany 15 211 1.1× 337 2.0× 114 1.1× 94 1.6× 31 0.8× 21 507
Stephen C. Yabut United States 10 205 1.1× 210 1.2× 37 0.4× 25 0.4× 23 0.6× 14 417
Sai Kumar Chakka South Africa 12 164 0.9× 139 0.8× 28 0.3× 46 0.8× 17 0.4× 17 314
Su-Jun Deng United States 6 47 0.3× 186 1.1× 30 0.3× 47 0.8× 48 1.2× 7 399
Rajeev S. Bhide United States 13 234 1.3× 217 1.3× 96 1.0× 37 0.6× 23 0.6× 19 461
Richard Heng Switzerland 12 108 0.6× 256 1.5× 75 0.7× 32 0.6× 24 0.6× 17 373

Countries citing papers authored by Zhonghui Lu

Since Specialization
Citations

This map shows the geographic impact of Zhonghui Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhonghui Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhonghui Lu more than expected).

Fields of papers citing papers by Zhonghui Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhonghui Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhonghui Lu. The network helps show where Zhonghui Lu may publish in the future.

Co-authorship network of co-authors of Zhonghui Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhonghui Lu. A scholar is included among the top collaborators of Zhonghui Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhonghui Lu. Zhonghui Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
3.
Chen, Li, Yunfei Hu, Zhonghui Lu, et al.. (2023). Design, Synthesis, and Antitumor Efficacy of Substituted 2-Amino[1,2,4]triazolopyrimidines and Related Heterocycles as Dual Inhibitors for Microtubule Polymerization and Janus Kinase 2. Journal of Medicinal Chemistry. 66(21). 15006–15024. 11 indexed citations
4.
Duan, James J.‐W., Bin Jiang, Zhonghui Lu, et al.. (2020). Discovery of 2,6–difluorobenzyl ether series of phenyl ((R)–3–phenylpyrrolidin–3–yl)sulfones as surprisingly potent, selective and orally bioavailable RORγt inverse agonists. Bioorganic & Medicinal Chemistry Letters. 30(19). 127441–127441. 4 indexed citations
5.
Lu, Zhonghui, Gregory R. Ott, Rajan Anand, et al.. (2008). Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-α converting enzyme (TACE): Discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1′ substituents. Bioorganic & Medicinal Chemistry Letters. 18(6). 1958–1962. 53 indexed citations
6.
Ott, Gregory R., Naoyuki Asakawa, Zhonghui Lu, et al.. (2008). Potent, exceptionally selective, orally bioavailable inhibitors of TNF-α Converting Enzyme (TACE): Novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1′ substituents. Bioorganic & Medicinal Chemistry Letters. 18(5). 1577–1582. 41 indexed citations
7.
Duan, James J.‐W., Lihua Chen, Zhonghui Lu, et al.. (2007). Discovery of β-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(1). 241–246. 23 indexed citations
8.
Ott, Gregory R., Naoyuki Asakawa, Zhonghui Lu, et al.. (2007). α,β-Cyclic-β-benzamido hydroxamic acids: Novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-α converting enzyme (TACE). Bioorganic & Medicinal Chemistry Letters. 18(2). 694–699. 31 indexed citations
9.
Duan, James J.‐W., Lihua Chen, Zhonghui Lu, et al.. (2006). Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-α converting enzyme (TACE). Bioorganic & Medicinal Chemistry Letters. 17(1). 266–271. 45 indexed citations
10.
Duan, James J.‐W., Zhonghui Lu, Zelda R. Wasserman, et al.. (2005). Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-α converting enzyme. Bioorganic & Medicinal Chemistry Letters. 15(12). 2970–2973. 28 indexed citations
11.
Duan, James J.‐W., Zhonghui Lu, Chu‐Biao Xue, et al.. (2003). Discovery of N-Hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-α converting enzyme (TACE). Bioorganic & Medicinal Chemistry Letters. 13(12). 2035–2040. 29 indexed citations
12.
Duan, James J.‐W., Lihua Chen, Zelda R. Wasserman, et al.. (2002). Discovery of γ-Lactam Hydroxamic Acids as Selective Inhibitors of Tumor Necrosis Factor α Converting Enzyme:  Design, Synthesis, and Structure−Activity Relationships. Journal of Medicinal Chemistry. 45(23). 4954–4957. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Roderick Breakdown of academic impact, for papers by John L. Gilmore Breakdown of academic impact, for papers by John G. Catalano Breakdown of academic impact, for papers by Attilla Ting Breakdown of academic impact, for papers by Manfred Schudok Breakdown of academic impact, for papers by Stephen C. Yabut Breakdown of academic impact, for papers by Sai Kumar Chakka Breakdown of academic impact, for papers by Su-Jun Deng Breakdown of academic impact, for papers by Rajeev S. Bhide Breakdown of academic impact, for papers by Richard Heng
Rankless by CCL
2026